I feel privileged to be part of The Ohio State University medical community, and I’m especially proud to contribute to the overall OSUCCC – James mission: cutting-edge research and the delivery of superior, individualized care to each and every one of our patients.
A lot of my work has been in clinical and laboratory research, evaluating everything from the effectiveness of ionizing radiation treatments to trials aimed at determining ways to mitigate the undesired side-effects of certain treatment regimens. It’s my hope that this and the other research we do will not only help us ultimately create a cancer-free world, but also ease the suffering of patients while we’re on the way to achieving that goal.
I’ve contributed to 17 peer-reviewed publications, which cover topics ranging from therapies to treat bone and extremity soft-tissue sarcomas to radiation therapy for symptomatic persistent endometriosis. I also have numerous presentations at national conferences.
In addition to my work at OSUCCC – James, I mentor radiation oncology fellows and students.
Yale University School of Medicine
Harvard Radiation Oncology Program
7/1/2005 - 6/30/2009
Specialties and conditions I treat
- Radiation Oncology
- Lung Cancers
- Radiotherapy, Image-Guided
- Lung Cancers
- Soft Tissue Cancers
- Mediastinal Cancers
- Tracheal Tumors
- Connective and Soft Tissue Cancers
- Retroperitoneal Cancers
- Thymus Cancers
- Carcinoma, Adenosquamous
- Carcinoma, Large Cell
- Carcinoma, Small Cell
- Respiratory Cancers
- Cranial Irradiation
- Radiotherapy, Computer-Assisted
- Radiotherapy, Conformal
- Radiotherapy, Intensity-Modulated
- Dose Fractionation
- Radiotherapy Dosage
- Radiotherapy, Adjuvant
- Adenocarcinoma, Bronchiolo-Alveolar
- Radiotherapy Setup Errors
- Sarcoma, Kaposi
Locations where I practice
More about my work
American Board of Radiology (Subspecialty: Diagnostic Radiology)
At The Ohio State University Wexner Medical Center, we support a faculty member’s research and consulting in collaboration with medical device, research and/or drug companies because a faculty member’s expertise can guide important advancements in the practice of medicine and improve patient care. In order to provide effective management of these relationships, the University requires annual disclosures from all faculty members with external interests related to their University responsibilities.
As of 03/25/2016, Dr. Haglund has reported no financial relationships with medical device, research and/or drug companies.